Phase 4 trials
Phase 4 trials
Explore registered studies and their research locations.4,277 results · Page 1 of 172
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| The Safety of Simplified Tranexamic Acid Regimen | Hemic and Lymphatic Diseases, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cardiovascular disorder, hematologic disorder, hemorrhagic disease, injury, vascular disorder, vascular hemostatic disease | Recruiting | Phase 4 | 2026-10-09 | NCT07869537 | |
| Evaluation of Ophtholic Ultra for Ocular Surface Protection After Cataract Surgery | dry eye syndrome, eye disorder, lacrimal apparatus disorder | Active, not recruiting | Phase 4 | 2026-10-09 | NCT07868965 | |
| Community Active and Healthy Families Pragmatic Trial | Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Pediatric Obesity, Signs and Symptoms, nutritional disorder, obesity disorder, overnutrition | Not yet recruiting | Phase 4 | 2026-10-09 | NCT07868471 | |
| Botulinum Toxin Type A Versus Triamcinolone for Facial Myalgia | Facial Pain, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, muscle tissue disorder, musculoskeletal system disorder, myofascial pain syndrome | Not yet recruiting | Phase 4 | 2026-10-09 | NCT07867379 | |
| E-Type - Early Wear of Polyethylene Liners Used in DMC | Hip Dislocation, Hip Injuries, Joint Dislocations, Necrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, arthritic joint disease, arthropathy, bone disorder, injury, musculoskeletal system disorder, osteoarthritis, osteonecrosis, rheumatic disorder | Recruiting | Phase 4 | 2026-10-09 | NCT07863557 | |
| Intraosseous Tranexamic Acid for Reducing Blood Loss in Total Knee Arthroplasty | arthritic joint disease, arthropathy, musculoskeletal system disorder, osteoarthritis, osteoarthritis, knee, rheumatic disorder | Not yet recruiting | Phase 4 | 2026-10-09 | NCT07853885 | |
| Infliximab for Immune Checkpoint Inhibitor Associated AKI | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Urogenital Diseases, acute kidney injury, acute tubulointerstitial nephritis, kidney disorder, kidney failure, urinary system disorder | Recruiting | Phase 4 | 2026-10-09 | NCT07683975 | |
| Carbetocin Monotherapy Versus Carbetocin Plus Oxytocin Infusion in Elective Cesarean Delivery: A Non-Inferiority Trial | Blood Loss, Surgical, Female Urogenital Diseases and Pregnancy Complications, Hemorrhage, Intraoperative Complications, Obstetric Labor Complications, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Postpartum Hemorrhage, Urogenital Diseases, Uterine Hemorrhage, Uterine Inertia, dystocia, pregnancy disorder, puerperal disorder | Recruiting | Phase 4 | 2026-10-09 | NCT07636421 | |
| Cervicothoracic Sympathetic Block Evaluation for Post COVID Condition | autonomic nervous system disorder, nervous system disorder, primary dysautonomia | Recruiting | Phase 4 | 2026-10-09 | NCT07468604 | |
| Tranexamic Acid for Bleeding Reduction During TURP Surgery | Genital Diseases, Hemic and Lymphatic Diseases, Male Urogenital Diseases, Urogenital Diseases, anemia, benign prostatic hyperplasia, hematologic disorder, male reproductive system disorder, prostate disorder | Recruiting | Phase 4 | 2026-10-09 | NCT07460518 | |
| Finerenone Plus SGLT2 Inhibitors in Heart Failure | cardiovascular disorder, heart disorder, heart failure | Active, not recruiting | Phase 4 | 2026-10-09 | NCT07351864 | |
| Acceptability and Feasibility of Extended-Release Subcutaneous Buprenorphine on a Mobile Pharmacy Clinic | Chemically-Induced Disorders, Narcotic-Related Disorders, Opioid Use Disorder, opiate dependence, psychiatric disorder, substance-related disorder | Recruiting | Phase 4 | 2026-10-09 | NCT07176351 | |
| Biotivity A-C Membrane Socket Preservation Study | Alveolar Ridge Preservation | Recruiting | Phase 4 | 2026-10-09 | NCT07091448 | |
| Doxycycline Prophylaxis for Prevention of Sexually Transmitted Infections | Bacterial Infections and Mycoses, Disease Attributes, Genital Diseases, Infections, Neisseriaceae Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Treponema infectious disease, Urogenital Diseases, bacterial infectious disease, bacterial sexually transmitted disease, chlamydia infectious disease, chlamydiaceae infections, gonorrhea, gram-negative bacterial infections, infectious disease, sexually transmitted disease, spirochaetales infections, syphilis | Recruiting | Phase 4 | 2026-10-09 | NCT06738407 | |
| PRP for Glenohumeral Osteoarthritis | Shoulder Osteoarthritis | Recruiting | Phase 4 | 2026-10-09 | NCT05675527 | |
| Roll-over Study to Allow Continued Access to Ribociclib | Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder | Active, not recruiting | Phase 4 | 2026-10-09 | NCT05161195 | |
| Single Dose Intravenous Antibiotics for Complicated Urinary Tract Infections in Children | Infections | Recruiting | Phase 4 | 2026-10-09 | NCT04876131 | |
| Southeast Asia Dose Optimization of Tafenoquine | Disease Attributes, Infections, Mosquito-Borne Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Plasmodium vivax malaria, Recurrence, malaria, parasitic infectious disease, protozoa infectious disease, vector-borne disease | Recruiting | Phase 4 | 2026-10-09 | NCT04704999 | |
| Dabrafenib and/or Trametinib Rollover Study | Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Skin and Connective Tissue Diseases, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, epithelial neoplasm, glioma, lung disorder, lung neoplasm, malignant glioma, melanocytic neoplasm, melanoma, neoplasm, neuroendocrine neoplasm, neuroepithelial neoplasm, non-small cell lung carcinoma, primitive neuroectodermal tumor, respiratory system disorder, respiratory tract neoplasm, skin disorder, skin neoplasm | Recruiting | Phase 4 | 2026-10-09 | NCT03340506 | |
| LMWH vs Aspirin for VTE Prophylaxis in Orthopaedic Oncology | Embolism and Thrombosis, Hematoma, Hemorrhage, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Connective and Soft Tissue, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Thromboembolism, bone disorder, bone sarcoma, cardiovascular disorder, musculoskeletal system disorder, neoplasm, sarcoma, vascular disorder, venous thromboembolism | Enrolling by invitation | Phase 4 | 2026-10-09 | NCT03244020 | |
| Suzetrigine for Analgesiain Arthroscopic Rotator Cuff Repair | Neurobehavioral Manifestations, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, agnosia, nervous system disorder, perceptual disorders | Not yet recruiting | Phase 4 | 2026-10-08 | NCT07866638 | |
| Evaluation of Polidocanol Foam Sclerotherapy in Symptomatic Internal Hemorrhoids: A Prospective Study | Internal Hemorrhoids; Internal Piles Sclerotherapy | Not yet recruiting | Phase 4 | 2026-10-08 | NCT07866248 | |
| Vaginal Lactobacillus for Postoperative Microecology and Mucosal Repair in MRKH Syndrome | Mayer-Rokitansky-Kuster-Hauser syndrome, mullerian aplasia | Not yet recruiting | Phase 4 | 2026-10-08 | NCT07865559 | |
| Effect of Labetalol, Magnesium Sulfate, or Lidocaine on Opioid Consumption During Laparoscopic Cholecystectomy | Digestive System Diseases, Neurologic Manifestations, Pain, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Postoperative Complications, Postoperative Pain, Signs and Symptoms, biliary tract disorder, cholelithiasis | Not yet recruiting | Phase 4 | 2026-10-08 | NCT07865455 | |
| These Studies That Evaluated the Efficacy of Antibiotics for Leptospirosis Treatment. | Bacterial Infections and Mycoses, Infections, bacterial infectious disease, gram-negative bacterial infections, leptospirosis, spirochaetales infections | Not yet recruiting | Phase 4 | 2026-10-08 | NCT07865156 |